Trump’s Drug Pricing Executive Order, Explained (Again)
Recycled, blocked, performative—and now, back from the grave for a second act of failure.
Next week, President Donald Trump is expected to sign a new executive order to lower prescription drug prices for Medicare recipients. The order, which revives the so-called “Most Favored Nation” model, would peg the cost of certain medications to what other wealthy nations pay. Administration officials are calling it bold. They say it delivers on Trump…




